Search form
Search
contact us
Navigation
home
boards
job center
job ratings
cp wire
device news
pharmagather
catering
advertise
Legal Help
login/register
You are here
Home
»
companies
» chronic spontaneous urticaria
chronic spontaneous urticaria
Novartis gets FDA breakthrough therapy status for ligelizumab to treat chronic spontaneous urticaria
Novartis gets FDA breakthrough therapy status for ligelizumab to treat chronic spontaneous urticaria
Pharmaceutical Business Review
Novartis
breakthrough therapy
FDA
ligelizumab
chronic spontaneous urticaria
Flag link:
Novartis gets EC approval for self-administration of Xolair across all indications
Novartis gets EC approval for self-administration of Xolair across all indications
Pharmaceutical Business Review
Novartis
Xolair
severe allergic asthma
chronic spontaneous urticaria
Flag link:
Novartis' omalizumab shines in third PhIII hives trial
Novartis' omalizumab shines in third PhIII hives trial
Pharma Times, UK
Novartis
chronic spontaneous urticaria
omalizumab
Xolair
Genentech
Flag link:
